Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study
- 15 March 1985
- Vol. 55 (6), 1284-1290
- https://doi.org/10.1002/1097-0142(19850315)55:6<1284::aid-cncr2820550622>3.0.co;2-b
Abstract
Four hundred patients with resectable colon and rectal cancers were operated on by 37 surgeons at 31 institutions. Patients were monitored with carcinoembryonic antigen (CEA) level determinations and clinical examinations. One hundred thirty patients had recurrences, and 75 were reoperated on, with 43 reoperations CEA-directed and 32 clinically directed. Two of 75 died within 1 month after the second operation. Twenty-two second-look patients remain free of disease 5 years after their second operaton. The highest resectability of recurrent cancer occurred in patients with a CEA level below 11 ng/ml in whom the CEA level was determined at intervals of 1 to 2 months. Cancer 55:1284-1290, 1985.Keywords
This publication has 6 references indexed in Scilit:
- The use of serial CEA determinations to predict recurrence of colon cancer and when to do a second-look operationCancer, 1978
- Carcinoembryonic Antigen Test for Recurrent Colorectal CarcinomaPublished by American Medical Association (AMA) ,1978
- The USE of CEA as an early indicator for gastrointestinal tumor recurrence and second-look proceduresCancer, 1977
- Carcinoembryonic antigen in colorectal practiceDiseases of the Colon & Rectum, 1976
- Carcinoembryonic antigen. Clinical and historical aspectsCancer, 1976
- DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUESThe Journal of Experimental Medicine, 1965